Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004577-23Phase 4Completed
Phase 4, randomised trial of remifentanil (2 arms), sponsored by University of Bergen. Primary endpoint: Satisfying pain relief enabling spontaneous labour. Started Oct 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004577-23.